药明巨诺-B
港股通 官网
( 02126.hk)
市盈率-0.79市净率0.34市销率2.89股息率0.00%上市时间2020-11-03股价1.32港币 (-4.35% , 79.48万港币) 市值5.48亿港币总股本4.15亿上市至今年化投资收益率-49.61%
所属三级行业生物技术 (恒生) 市盈率-49.59市净率2.75市销率5.16股息率0.63%
备注 (0): 双击编辑备注
发表讨论

药明巨诺-B(02126) - 历史董事名单

# 姓名职衔职位委任日期辞任日期
1LEE Li AnnIndependent Non Executive Director2023-08-29--
2SONG Sung WonNon Executive Director2023-08-29--
3VISWANADHAN KrishnanIndependent Non Executive Director2023-08-29--
4余久筠Independent Non Executive Director2023-03-01--
5張耀樑Independent Non Executive Director - A/F2020-10-22--
6何建昌Independent Non Executive Director - A/F2020-10-22--
7李志成Independent Non Executive Director2020-10-222023-01-01
8劉誠Non Executive Director2020-06-30--
9高星Non Executive Director2020-05-22--
10LEE Li AnnNon Executive Director2020-05-222023-08-29
11王金印Non Executive Director2020-05-222023-08-29
12曹彥凌Independent Non Executive Director2020-05-222021-12-03
13VISWANADHAN KrishnanNon Executive Director2019-11-202023-08-29
14李怡平Executive DirectorChairman, CEO2017-11-14--
15BISHOP Hans EdgarNon Executive Director2017-11-142021-12-03